ticlopidine

(redirected from ticlopidine hydrochloride)
Also found in: Medical.
Related to ticlopidine hydrochloride: Ticlid

ti·clo·pi·dine

 (tī-klō′pə-dēn′)
n.
A drug that blocks platelet aggregation, C14H14ClNS, used in its hydrochloride form to prevent stroke and to treat intermittent claudication.

[t(h)i(o)- + c(h)lo(ro)- + p(yr)idine.]
References in periodicals archive ?
A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients.
Between July 2001 and June this year, 17 people died of liver problems or thrombotic thrombocytopenic purpura (TTP) after being given an antiplatelet called ticlopidine hydrochloride, according to the Health, Labor and Welfare Ministry.
s antifungal Nizoral, and ticlopidine hydrochloride tablets, AB-rated and bioequivalent to Roche Laboratories Inc.
Ticlopidine hydrochloride, a recently developed drug, has been proven to be more effective in preventing strokes than aspirin or placebos, according to two recent studies.
Subsequent to the quarter's end, FDA tentative approvals have been received for Famotidine (3 strengths), Ketoconazole and Ticlopidine Hydrochloride.
the supplier entered the market in the United States earlier this year by introducing ticlopidine hydrochloride, which is said to help reduce the risk of stroke and is comparable to Roche Laboratories' Ticlid.
In the six cases of death, the patients developed thrombotic thrombocytopenic purpura (TTP), a life-threatening hematological reaction resulting from ticlopidine hydrochloride treatment, the officials said.